Literature DB >> 9701031

Microglia are more susceptible than macrophages to apoptosis in the central nervous system in experimental autoimmune encephalomyelitis through a mechanism not involving Fas (CD95).

C A White1, P A McCombe, M P Pender.   

Abstract

Morphological studies have shown that macrophages and microglia undergo apoptosis in the central nervous system (CNS) in acute experimental autoimmune encephalomyelitis (EAE) in the Lewis rat. To assess the relative levels of macrophage and microglial apoptosis, and the molecular mechanisms involved in this process, we used three-colour flow cytometry to identify CD45lowCD11b/c+ microglial cells and CD45highCD11b/c+ macrophages in the inflammatory cells isolated from the spinal cords of Lewis rats 13 days after immunization with myelin basic protein (MBP) and complete Freund's adjuvant. Simultaneously, we analyzed the DNA content of these cell populations to assess the proportions of cells undergoing apoptosis and in different stages of the cell cycle or examined their expression of three apoptosis-regulating proteins, i.e. Fas (CD95), Fas ligand (FasL) and Bcl-2. Microglia were highly vulnerable to apoptosis and were over-represented in the apoptotic population. Macrophages were less susceptible to apoptosis than microglia and underwent mitosis more frequently than microglia. The different susceptibilities of microglia and macrophages to apoptosis did not appear to be due to variations in Fas, FasL or Bcl-2 expression, as the proportions of microglia and macrophages expressing these proteins were similar, and were relatively high. Furthermore, in contrast to T cell apoptosis, apoptosis of microglia/macrophages did not occur more frequently in cells expressing Fas or FasL, or less frequently in cells expressing Bcl-2. These results indicate that the apoptosis of microglia and CNS macrophages in EAE is not mediated through the Fas pathway, and that Bcl-2 expression does not protect them from apoptosis. Expression of FasL by macrophages and microglia may contribute to the pathogenesis and immunoregulation of EAE through interactions with Fas+ oligodendrocytes and Fas+ T cells. The high level of microglial apoptosis in EAE indicates that microglial apoptosis may be an important homeostatic mechanism for controlling the number of microglia in the CNS following microglial activation and proliferation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9701031     DOI: 10.1093/intimm/10.7.935

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  13 in total

1.  Macrophages are eliminated from the injured peripheral nerve via local apoptosis and circulation to regional lymph nodes and the spleen.

Authors:  T Kuhlmann; A Bitsch; C Stadelmann; H Siebert; W Brück
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

2.  T-cell properties determine disease site, clinical presentation, and cellular pathology of experimental autoimmune encephalomyelitis.

Authors:  Sara Abromson-Leeman; Rod Bronson; Yi Luo; Michael Berman; Rebecca Leeman; Joshua Leeman; Martin Dorf
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

3.  Neuroprotective Effects on the Morphology of Somatic Motoneurons Following the Death of Neighboring Motoneurons: A Role for Microglia?

Authors:  Cory Chew; Brandon J Kiley; Dale R Sengelaub
Journal:  Dev Neurobiol       Date:  2019-01-07       Impact factor: 3.964

4.  Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis.

Authors:  G C Suvannavejh; M C Dal Canto; L A Matis; S D Miller
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

5.  Dual role of CD38 in microglial activation and activation-induced cell death.

Authors:  Lior Mayo; Jasmine Jacob-Hirsch; Ninette Amariglio; Gideon Rechavi; Marie-Jo Moutin; Frances E Lund; Reuven Stein
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

6.  High-mobility group box 1 is an important mediator of microglial activation induced by cortical spreading depression.

Authors:  Tsubasa Takizawa; Mamoru Shibata; Yohei Kayama; Toshihiko Shimizu; Haruki Toriumi; Taeko Ebine; Miyuki Unekawa; Anri Koh; Akihiko Yoshimura; Norihiro Suzuki
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

7.  Population control of resident and immigrant microglia by mitosis and apoptosis.

Authors:  Martin Wirenfeldt; Lasse Dissing-Olesen; Alicia Anne Babcock; Marianne Nielsen; Michael Meldgaard; Jens Zimmer; Iñigo Azcoitia; Robert Graham Quinton Leslie; Frederik Dagnaes-Hansen; Bente Finsen
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

8.  The changing phenotype of microglia from homeostasis to disease.

Authors:  Xiao-Guang Luo; Sheng-Di Chen
Journal:  Transl Neurodegener       Date:  2012-04-24       Impact factor: 8.014

9.  Developmental stage of oligodendrocytes determines their response to activated microglia in vitro.

Authors:  Brandon A Miller; Jeannine M Crum; C Amy Tovar; Adam R Ferguson; Jacqueline C Bresnahan; Michael S Beattie
Journal:  J Neuroinflammation       Date:  2007-11-26       Impact factor: 8.322

10.  Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype.

Authors:  Konstantin Dirscherl; Marcus Karlstetter; Stefanie Ebert; Dominik Kraus; Julia Hlawatsch; Yana Walczak; Christoph Moehle; Rudolf Fuchshofer; Thomas Langmann
Journal:  J Neuroinflammation       Date:  2010-01-14       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.